Clinical trial
Aortic Valve Neocuspidization With Glutaraldehyde-Treated Autologous Pericardium
NCT05411055 is registered in ClinicalTrials.gov with Maria Cecilia Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aortic Valve Neocuspidization With Glutaraldehyde-Treated Autologous Pericardium
- Lead sponsor
- Maria Cecilia Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- June 6, 2021
- Completion date
- June 6, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.